Laboratorios Sanfer announces Chile entry
Laboratorios Sanfer anuncia su llegada a Chile
Intel ID : 235634
| Synopsis |
|
Laboratorios Sanfer, a Mexican pharmaceutical company, announced its entry in the Chilean market, as published by agency Notimex on 15 April 2016, citing its general manager, Ricardo Amtmann Aguilar. On the other hand, Sanfer's general manager for Chile, Rodrigo Fuenzalida, said this entry will begin through the opening of a commercial office in Santiago de Chile, and at a later stage the company will integrate all its divisions. Laboratorios Sanfer's estimated investment in Chile is approximately USD 5m, and the company expects to continue its expansion in Latin America.
(content in spanish)
Laboratorios Sanfer, empresa mexicana especializada en la industria farmacéutica, ha anunciado el inicio de sus operaciones en el mercado chileno,según ha informado la agencia Notimex el 15 de abril de 2016, citando al presidente y director general de Laboratorios Sanfer, Ricardo Amtmann Aguilar. Por su parte, el gerente general de Sanfer en Chile, Rodrigo Fuenzalida, ha afirmado que la llegada iniciará con la apertura de una oficina comercial en Santiago de Chile y luego se integrarán todas las divisiones de la empresa en general. La inversión que ha estimado Laboratorios Sanfer en Chile ha sido de alrededor USD 5m y espera continuar su etapa de expansión en el resto de América Latina. |
| Intel ID | 235634 | |
| Value | ND | |
| Native Currency |
US Dollar (USD)
Exchange Rate:  |
|
| Date |
 |
|
| Country | |
|
| Region | ||
| Continent | |
|
| Geography | |
|
| Subsector (Old TTR Sectors) |
|
|
| Type |
|
|
| Intel Grade |
|
|
| Source |
|
|
| Tags | |
Bidder
| Name |
|
||
| Subsector (Old TTR Sectors) |
|
||
| Primary Sector (TTRSC) |
30.01.03 Pharmaceutical R&D, Manufacturing & Distribution 30 Healthcare / 30.01 Biotechnology & Pharmaceuticals |
||
| Country |
|
||
| Website |
|
||
| Description |
|
Legend:
Verified: Confirmed as a party to an active or possible transaction.
Potential: Unconfirmed as a party to an active or possible transaction.
Retained: Confirmed as “Retained” with a general or specific mandate.
Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.
Transactional data is continuously updated by the research team and therefore is subject to change.